Biopsy evaluation of chronic active hepatitis. Peritoneoscopy with directed liver biopsy versus blind percutaneous liver biopsy

D. H. Wytock, T. W. Coleman, J. R. Sharp, Charles E Brady Iii, J. A. Baybick, J. W. Bagnall

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In this prospective study of chronic liver disease, we compared the assessment of hepatic histology in samples obtained by peritoneoscopy with directed liver biopsy and blind percutaneous liver biopsy in 23 cases (22 patients, one patient studied twice). In blinded fashion, a pathologist assessed all specimens for evidence of cirrhosis and degree of necroinflammatory change. Two clinicians independently reviewed clinical and laboratory findings in both sets of biopsies. Each committed in writing recommendations regarding immunosuppressive therapy, follow-up interval, and rebiopsy date. The final diagnosis differed from that made by percutaneous and directed biopsy in 2 of 23 (9%) and 1 of 23 (4%) cases, respectively. Six cases of cirrhosis were correctly diagnosed by both biopsy methods, but only four of the six cirrhotic cases were diagnosed by gross peritoneoscopic findings. In only 2 of 23 (9%) cases was there disagreement in the degree of necroinflammatory change between the blind and directed biopsies that affected treatment recommendations. We conclude that blind percutaneous biopsy adequately diagnoses and monitors activity in viral chronic hepatitis for treatment purposes.

Original languageEnglish (US)
Pages (from-to)320-323
Number of pages4
JournalJournal of Clinical Gastroenterology
Volume10
Issue number3
StatePublished - 1988

Fingerprint

Chronic Hepatitis
Laparoscopy
Biopsy
Liver
Fibrosis
Immunosuppressive Agents
Liver Diseases
Histology
Chronic Disease
Therapeutics
Prospective Studies

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Wytock, D. H., Coleman, T. W., Sharp, J. R., Brady Iii, C. E., Baybick, J. A., & Bagnall, J. W. (1988). Biopsy evaluation of chronic active hepatitis. Peritoneoscopy with directed liver biopsy versus blind percutaneous liver biopsy. Journal of Clinical Gastroenterology, 10(3), 320-323.

Biopsy evaluation of chronic active hepatitis. Peritoneoscopy with directed liver biopsy versus blind percutaneous liver biopsy. / Wytock, D. H.; Coleman, T. W.; Sharp, J. R.; Brady Iii, Charles E; Baybick, J. A.; Bagnall, J. W.

In: Journal of Clinical Gastroenterology, Vol. 10, No. 3, 1988, p. 320-323.

Research output: Contribution to journalArticle

Wytock, DH, Coleman, TW, Sharp, JR, Brady Iii, CE, Baybick, JA & Bagnall, JW 1988, 'Biopsy evaluation of chronic active hepatitis. Peritoneoscopy with directed liver biopsy versus blind percutaneous liver biopsy', Journal of Clinical Gastroenterology, vol. 10, no. 3, pp. 320-323.
Wytock, D. H. ; Coleman, T. W. ; Sharp, J. R. ; Brady Iii, Charles E ; Baybick, J. A. ; Bagnall, J. W. / Biopsy evaluation of chronic active hepatitis. Peritoneoscopy with directed liver biopsy versus blind percutaneous liver biopsy. In: Journal of Clinical Gastroenterology. 1988 ; Vol. 10, No. 3. pp. 320-323.
@article{bbf8ca4b79634319a28dc93b721c7b70,
title = "Biopsy evaluation of chronic active hepatitis. Peritoneoscopy with directed liver biopsy versus blind percutaneous liver biopsy",
abstract = "In this prospective study of chronic liver disease, we compared the assessment of hepatic histology in samples obtained by peritoneoscopy with directed liver biopsy and blind percutaneous liver biopsy in 23 cases (22 patients, one patient studied twice). In blinded fashion, a pathologist assessed all specimens for evidence of cirrhosis and degree of necroinflammatory change. Two clinicians independently reviewed clinical and laboratory findings in both sets of biopsies. Each committed in writing recommendations regarding immunosuppressive therapy, follow-up interval, and rebiopsy date. The final diagnosis differed from that made by percutaneous and directed biopsy in 2 of 23 (9{\%}) and 1 of 23 (4{\%}) cases, respectively. Six cases of cirrhosis were correctly diagnosed by both biopsy methods, but only four of the six cirrhotic cases were diagnosed by gross peritoneoscopic findings. In only 2 of 23 (9{\%}) cases was there disagreement in the degree of necroinflammatory change between the blind and directed biopsies that affected treatment recommendations. We conclude that blind percutaneous biopsy adequately diagnoses and monitors activity in viral chronic hepatitis for treatment purposes.",
author = "Wytock, {D. H.} and Coleman, {T. W.} and Sharp, {J. R.} and {Brady Iii}, {Charles E} and Baybick, {J. A.} and Bagnall, {J. W.}",
year = "1988",
language = "English (US)",
volume = "10",
pages = "320--323",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Biopsy evaluation of chronic active hepatitis. Peritoneoscopy with directed liver biopsy versus blind percutaneous liver biopsy

AU - Wytock, D. H.

AU - Coleman, T. W.

AU - Sharp, J. R.

AU - Brady Iii, Charles E

AU - Baybick, J. A.

AU - Bagnall, J. W.

PY - 1988

Y1 - 1988

N2 - In this prospective study of chronic liver disease, we compared the assessment of hepatic histology in samples obtained by peritoneoscopy with directed liver biopsy and blind percutaneous liver biopsy in 23 cases (22 patients, one patient studied twice). In blinded fashion, a pathologist assessed all specimens for evidence of cirrhosis and degree of necroinflammatory change. Two clinicians independently reviewed clinical and laboratory findings in both sets of biopsies. Each committed in writing recommendations regarding immunosuppressive therapy, follow-up interval, and rebiopsy date. The final diagnosis differed from that made by percutaneous and directed biopsy in 2 of 23 (9%) and 1 of 23 (4%) cases, respectively. Six cases of cirrhosis were correctly diagnosed by both biopsy methods, but only four of the six cirrhotic cases were diagnosed by gross peritoneoscopic findings. In only 2 of 23 (9%) cases was there disagreement in the degree of necroinflammatory change between the blind and directed biopsies that affected treatment recommendations. We conclude that blind percutaneous biopsy adequately diagnoses and monitors activity in viral chronic hepatitis for treatment purposes.

AB - In this prospective study of chronic liver disease, we compared the assessment of hepatic histology in samples obtained by peritoneoscopy with directed liver biopsy and blind percutaneous liver biopsy in 23 cases (22 patients, one patient studied twice). In blinded fashion, a pathologist assessed all specimens for evidence of cirrhosis and degree of necroinflammatory change. Two clinicians independently reviewed clinical and laboratory findings in both sets of biopsies. Each committed in writing recommendations regarding immunosuppressive therapy, follow-up interval, and rebiopsy date. The final diagnosis differed from that made by percutaneous and directed biopsy in 2 of 23 (9%) and 1 of 23 (4%) cases, respectively. Six cases of cirrhosis were correctly diagnosed by both biopsy methods, but only four of the six cirrhotic cases were diagnosed by gross peritoneoscopic findings. In only 2 of 23 (9%) cases was there disagreement in the degree of necroinflammatory change between the blind and directed biopsies that affected treatment recommendations. We conclude that blind percutaneous biopsy adequately diagnoses and monitors activity in viral chronic hepatitis for treatment purposes.

UR - http://www.scopus.com/inward/record.url?scp=0023733921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023733921&partnerID=8YFLogxK

M3 - Article

C2 - 2980998

AN - SCOPUS:0023733921

VL - 10

SP - 320

EP - 323

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 3

ER -